Share This Page
Drug Price Trends for DOXYLAMINE-PYRIDOXINE
✉ Email this page to a colleague
Average Pharmacy Cost for DOXYLAMINE-PYRIDOXINE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DOXYLAMINE-PYRIDOXINE 10-10 MG | 70505-0100-10 | 1.28428 | EACH | 2025-05-21 |
| DOXYLAMINE-PYRIDOXINE 10-10 MG | 00378-4615-01 | 1.28428 | EACH | 2025-05-21 |
| DOXYLAMINE-PYRIDOXINE 10-10 MG | 00591-2132-01 | 1.28428 | EACH | 2025-05-21 |
| DOXYLAMINE-PYRIDOXINE 10-10 MG | 69452-0206-20 | 1.28428 | EACH | 2025-05-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Doxylamine-Pyridoxine
Introduction to Doxylamine-Pyridoxine
Doxylamine-pyridoxine, a combination of an antihistamine (doxylamine) and a vitamin (pyridoxine), is widely used for the treatment of nausea and vomiting during pregnancy. This medication is marketed under various brand names, including Diclegis and Diclectin.
Clinical Efficacy and Approval
The efficacy of doxylamine-pyridoxine has been established through clinical trials, particularly the DIC-301 randomized controlled trial, which led to its approval by the United States Food and Drug Administration (FDA)[1].
- This trial demonstrated a trend towards efficacy in reducing nausea and vomiting symptoms, although the statistical significance of the difference depended on the method of handling missing data[1].
Market Demand and Usage
Doxylamine-pyridoxine is recommended as a first-line treatment for nausea and vomiting during pregnancy, which ensures a steady demand for the medication.
- Given its widespread use, it is included in clinical practice guidelines and systematic reviews, further solidifying its market position[1].
Global Market Analysis
The global doxylamine market is segmented into several regions, including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
- The market size and growth rate are influenced by factors such as profit, product price, capacity, production, and supply-demand dynamics[3].
Regional Market Trends
- North America: This region is a significant market for doxylamine-pyridoxine due to the high prevalence of pregnancy-related nausea and vomiting and the availability of the medication.
- Europe: Similar to North America, Europe also sees a substantial demand driven by healthcare standards and the recommendation of doxylamine-pyridoxine in clinical guidelines.
- Asia Pacific: This region is expected to show significant growth due to increasing healthcare expenditure and a larger population base[3].
Pricing and Cost Analysis
The cost of doxylamine-pyridoxine can vary depending on the brand, generic availability, and pharmacy.
Brand Name Pricing
- Diclegis, a brand name for doxylamine-pyridoxine, costs around $353 for a supply of 100 tablets (10 mg-10 mg oral delayed release tablets)[5].
Generic Pricing
- A generic version of doxylamine-pyridoxine is available at a lower cost, approximately $203 for a supply of 100 tablets (10 mg-10 mg oral delayed release tablets)[2].
Discount Programs
- Discount cards, such as those offered by Drugs.com, can reduce the cost of the medication by up to 80% or more, making it more affordable for patients[2][5].
Price Projections
Current Market Pricing
- The current pricing for doxylamine-pyridoxine, both brand and generic, indicates a stable market with competitive pricing.
Future Trends
- The global doxylamine market is expected to grow at a compound annual growth rate (CAGR) from 2024 to 2031, driven by increasing demand and expanding healthcare access[3].
- Price stability is anticipated, with potential reductions due to increased generic competition and discount programs.
Competitive Landscape
The market for doxylamine-pyridoxine is characterized by both brand and generic offerings.
- The presence of generic versions, such as doxylamine-pyridoxine, competes directly with brand names like Diclegis, influencing pricing dynamics[2][5].
Regulatory Environment
The regulatory environment plays a crucial role in the market for doxylamine-pyridoxine.
- FDA approval and inclusion in clinical guidelines ensure a favorable regulatory backdrop, supporting the medication's market position[1].
Consumer Impact
The cost and availability of doxylamine-pyridoxine significantly impact consumers, particularly pregnant women.
- Affordable pricing and discount programs make the medication more accessible, improving health outcomes for this demographic[2][5].
Conclusion
Doxylamine-pyridoxine remains a vital medication for treating nausea and vomiting during pregnancy, with a strong market presence driven by clinical efficacy, regulatory approval, and consumer demand.
Key Takeaways
- Clinical Efficacy: Doxylamine-pyridoxine is effective in treating nausea and vomiting during pregnancy, supported by clinical trials.
- Market Demand: Steady demand due to its recommendation as a first-line treatment.
- Pricing: Brand and generic options available, with discount programs reducing costs.
- Future Growth: Expected growth in the global market, driven by increasing healthcare access and demand.
- Regulatory Support: FDA approval and inclusion in clinical guidelines support its market position.
FAQs
Q: What is doxylamine-pyridoxine used for?
A: Doxylamine-pyridoxine is used for the treatment of nausea and vomiting during pregnancy.
Q: Is doxylamine-pyridoxine FDA-approved?
A: Yes, doxylamine-pyridoxine is FDA-approved for the treatment of nausea and vomiting during pregnancy[1].
Q: How much does doxylamine-pyridoxine cost?
A: The cost varies between brand and generic versions, with brand names like Diclegis costing around $353 for 100 tablets and generic versions costing approximately $203 for 100 tablets[2][5].
Q: Are there any discount programs available for doxylamine-pyridoxine?
A: Yes, discount cards and programs can reduce the cost of doxylamine-pyridoxine by up to 80% or more[2][5].
Q: What is the expected growth rate of the global doxylamine market?
A: The global doxylamine market is expected to grow at a compound annual growth rate (CAGR) from 2024 to 2031, driven by increasing demand and healthcare access[3].
Sources
- PLOS ONE: Doxylamine-pyridoxine for nausea and vomiting of pregnancy: A randomized clinical trial.
- Drugs.com: Doxylamine/pyridoxine Prices, Coupons, Copay Cards & Patient Assistance.
- Cognitive Market Research: Global Doxylamine Market Report 2024 Edition.
- FDA: Clinical Pharmacology and Biopharmaceutics Review(s) - Diclegis.
- Drugs.com: Diclegis Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓
